Celmatix has appointed Daniel Farkas chief clinical laboratory officer for its new laboratory in Brooklyn, New York. He will be using his experience to lead the development of the new laboratory, which will conduct sequencing for the firm's genetic panel for fertility disorders.
Farkas has decades of experience in molecular diagnostics. He most recently worked as the lead laboratory director at Sequenom's clinical reference laboratories in San Diego; Grand Rapids, Michigan; and Morrisville, North Carolina. He has also served as president of the Association for Molecular Pathology; was the first professional to be certified in molecular diagnostics by the American Board of Bioanalysis; and has helped establish best practices in molecular pathology through his tenure on the College of American Pathologists' Molecular Pathology Resource Committee.